Silencing the PLK1 gene in combination with chemotherapy significantly inhibits tumors, promotes osteosarcoma cell apoptosis, and establishes a novel low-toxicity tactic for osteosarcoma clinical treatment. Here, PLK1 is linked to osteosarcoma.